Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss
Open Access
- 9 October 2014
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 1-9
Abstract
Aminoglycosides are a critical component of multidrug-resistant tuberculosis (MDR-TB) treatment but data on their efficacy and adverse effects in Botswana is scarce. We determined the effect of amikacin on treatment outcomes and development of hearing loss in MDR-TB patients. Patients started on MDR-TB treatment between 2006 and 2012 were included. Multivariate analysis was used to determine the effect of amikacin on treatment outcomes and development of hearing loss. 437 MDR-TB patients were included, 288 (66%) of whom were HIV co-infected. 270 (62%) developed hearing loss, of whom 147 (54%) had audiometry. Of the 313 (72%) patients who completed treatment, 228 (73%) had a good outcome (cure or treatment completion). Good outcome was associated with longer amikacin treatment (adjusted OR [aOR] 1.13, 95% CI 1.06 - 1.21) and higher dosage (aOR 1.90, 95% CI 1.12 – 2.99). Longer amikacin duration (aOR 1.98, 95% CI 1.86 – 2.12) and higher dosage per weight per month (aOR 1.15, 95% CI 1.04 – 1.28) were associated with development of hearing loss. Amikacin treatment duration modified the effect of the dosage on the risk of hearing loss, increasing this risk as the duration increased. Amikacin was effective for MDR-TB treatment, but was associated with a high incidence of hearing loss especially in our study population. Total treatment duration and average monthly amikacin dose were associated with improved outcomes; however these were also associated with development of hearing loss.Keywords
This publication has 38 references indexed in Scilit:
- COCKCROFT‐GAULT FORMULA FOR DIAGNOSING MODERATE KIDNEY FAILUREJournal of the American Geriatrics Society, 2008
- Performance of creatinine clearance equations on the original Cockcroft-Gault populationClinical Nephrology, 2006
- Predictive Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Estimating Renal FunctionJournal of the American Society of Nephrology, 2005
- Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of MycobacteriaJournal of Clinical Microbiology, 2004
- Multicenter Evaluation of Ethambutol Susceptibility Testing of Mycobacterium tuberculosis by Agar Proportion and Radiometric MethodsJournal of Clinical Microbiology, 2002
- Multicenter Evaluation of a Nonweekend Reading Schedule for Radiometric Pyrazinamide Susceptibility Testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2002
- High-Frequency Audiometric Monitoring for Early Detection of Aminoglycoside OtotoxicityThe Journal of Infectious Diseases, 1992
- Aminoglycoside-induced ototoxicityToxicology Letters, 1990
- The Association of Aminoglycoside Plasma Levels with Mortality in Patients with Gram-Negative BacteremiaThe Journal of Infectious Diseases, 1984
- Double-Blind Comparison of the Nephrotoxicity and Auditory Toxicity of Gentamicin and TobramycinNew England Journal of Medicine, 1980